Efficacy of piperacillin/tazobactam as initial empiric therapy of febrile neutropenia in patients with hematologic malignancy.

被引：0
|
作者：
Bow, EJ
Noskin, GA
Schwarer, AP
Laverdiere, M
Vesole, DH
机构：
[1] Univ Manitoba, Hlth Sci Ctr, Winnipeg, MB, Canada
[2] Northwestern Univ, Sch Med, Chicago, IL USA
[3] Alfred Hosp, Melbourne, Vic, Australia
[4] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
[5] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1000
引用
收藏
页码：281A / 281A
页数：1
相关论文
共 50 条
  • [31] Empiric antifungal therapy in febrile neutropenia
    Ramakrishnan N.
    Critical Care, 3 (1):
  • [32] Piperacillin/Tazobactam Versus Cefozopran for the Empirical Treatment of Pediatric Cancer Patients With Febrile Neutropenia
    Ichikawa, Mizuho
    Suzuki, Daisuke
    Ohshima, Junjiro
    Cho, Yuko
    Kaneda, Makoto
    Iguchi, Akihiro
    Ariga, Tadashi
    PEDIATRIC BLOOD & CANCER, 2011, 57 (07) : 1159 - 1162
  • [33] Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
    Alvarez, Jose C.
    Cuervo, Sonia I.
    Garzon, Javier R.
    Gomez, Julio C.
    Diaz, Jorge Augusto
    Silva, Edelberto
    Sanchez, Ricardo
    Cortes, Jorge A.
    BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14 : 59
  • [34] Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy
    Matsuoka, Hitoshi
    Tsukamoto, Atsuko
    Shirahashi, Akihiko
    Koga, Shin
    Suzushima, Hitoshi
    Shibata, Keisuke
    Uozumi, Kimiharu
    Yamashita, Kiyoshi
    Okamura, Seiichi
    Kawano, Fumio
    Tamura, Kazuo
    LEUKEMIA & LYMPHOMA, 2006, 47 (08) : 1618 - 1623
  • [35] Applications for the MASCC Risk Index for Febrile Neutropenia in Patients with Hematologic Malignancy
    O'Neal, Richard
    Roberts, Kandice
    Chen, Quan
    Huang, Bin
    Saeed, Hayder
    Ramlal, Reshma
    Monohan, Gregory
    Hildebrandt, Gerhard C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [36] Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia
    Karaman, Serap
    Vural, Sema
    Yildirmak, Yildiz
    Emecen, Merve
    Erdem, Ela
    Kebudi, Rejin
    PEDIATRIC BLOOD & CANCER, 2012, 58 (04) : 579 - 583
  • [37] Comparing ceftolozane/tazobactam versus piperacillin/tazobactam for the initial empiric therapy of urinary tract infections: A retrospective comparative study
    Nakagawa, Tomomi
    Shigehara, Kazuyoshi
    Shinzawa, Rei
    Yaegashi, Hiroshi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Izumi, Kouji
    Mizokami, Atsushi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (01) : 12 - 16
  • [38] IMIPENEM CILASTATIN VERSUS PIPERACILLIN PLUS AMIKACIN AS EMPIRIC THERAPY IN THE TREATMENT OF FEBRILE EPISODES IN NEUTROPENIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    VANDERCAM, B
    EZZEDDINE, H
    AGALIOTIS, D
    GALA, JL
    GIGI, J
    WAUTERS, G
    MICHAUX, JL
    ACTA CLINICA BELGICA, 1989, 44 (02): : 99 - 109
  • [39] Piperacillin-tazobactam monotherapy as management of febrile neutropenia in patients with acute leukaemia: A monocentric experience
    Fanci, R.
    Bartolozzi, B.
    Casini, C.
    Longo, G.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 155 - 155
  • [40] A META-ANALYSIS OF PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME TREATMENT IN CANCER PATIENTS WITH FEBRILE NEUTROPENIA
    Zhang Weidong
    Xiao Chun
    Zhou Sixin
    Wang Rui
    Wang Li
    Jia Liping
    Ma Jinqiu
    Wang Na
    BIOSCIENCE JOURNAL, 2016, 32 (06): : 1669 - 1678
12345